You are here » Home » Companies ยป Company Overview » Hester Biosciences Ltd

Hester Biosciences Ltd.

BSE: 524669 Sector: Health care
NSE: HESTERBIO ISIN Code: INE782E01017
BSE 00:00 | 01 Feb 1788.35 -80.15
(-4.29%)
OPEN

1949.00

HIGH

1949.00

LOW

1755.00

NSE 00:00 | 01 Feb 1784.95 -82.85
(-4.44%)
OPEN

1877.15

HIGH

1886.45

LOW

1754.95

OPEN 1949.00
PREVIOUS CLOSE 1868.50
VOLUME 425
52-Week high 2851.75
52-Week low 1701.00
P/E 49.04
Mkt Cap.(Rs cr) 1,522
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1949.00
CLOSE 1868.50
VOLUME 425
52-Week high 2851.75
52-Week low 1701.00
P/E 49.04
Mkt Cap.(Rs cr) 1,522
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Hester Biosciences Ltd. (HESTERBIO) - Company History

Incorporated as a private limited company in Apr.'87 Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.'93.HPL markets and distributes veterinary and pharmaceutical products like animal health products poultry vaccines poultry diagnostic laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation Japan; Maine Biological Laboratories US; Idexx Corporation US; International Diagnostic Systems Corporation US; Biogal Galed Laboratories Israel; and Kemin Europa Belgium.The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation.During 1996-97 company successfully implemented veterinary vaccine and commercial production has begun.The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.

.